Navigation Links
Edwards Lifesciences Forecasts Strong Growth in 2008
Date:12/7/2007

- EPS Growth of 11% to 14% Projected

- Expanded PARTNER Trial to Include Transapical System

- European Approval Received for Transapical System

NEW YORK, Dec. 7 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, today will provide investors with information on the initiatives expected to drive sales growth and profitability in 2008 and beyond. During its 2007 investor conference in New York City, Edwards' management will present details of the company's growth plans, market expansion opportunities and its financial outlook for 2008.

"We expect 2008 to be a very successful and important year for Edwards Lifesciences," said Michael A. Mussallem, chairman and CEO. "Our market-leading heart valve and critical care franchises provide a strong foundation for continued growth. We expect our strategic portfolio changes and sales of new products to drive greater profitability and grow earnings. Additionally, our market-expanding transcatheter valve technologies are expected to generate more than $20 million of sales next year."

During the conference, Edwards' management also will present the company's financial goals for 2008, including total sales between $1.16 billion to $1.21 billion, increasing gross profit margin by 100 to 150 basis points, delivering earnings per share growth of 11 to 14 percent, excluding the impact of special items, and generating free cash flow of $155 million to $165 million.
Among the specific topics to be discussed at today's event are:

-- Transcatheter Heart Valve Therapy -- Edwards continues to lead the

adv
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
2. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
3. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
6. STALLERGENES : Strong Business Growth: +17% and Earnings Per Share up 30%
7. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
8. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
9. U-M research: New plastic is strong as steel, transparent
10. Nobel Award in Medicine Holds Strong Messsage for Animal Activists
11. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... surface for label-free biomolecular interaction analysis now offers surface ... Protein A and Protein G for coupling antibodies. ... ... CA (PRWEB) February 8, 2010 -- Silicon Kinetics Inc., ... the world,s first 3D biosensor surface for label-free biomolecular ...
(Date:2/8/2010)... and NEW ORLEANS , Feb. 8 ... a worldwide developer and marketer of diagnostic test kits, ... extension of the collaborative effort to combat viral hemorrhagic ... $800,000 in contract revenue for Corgenix over ... Institutes of Health (NIH) has awarded a five-year contract ...
(Date:2/8/2010)... the ClearTrial clinical services team to present the critical processes ... clinical development departments. , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced that both ... have been selected to speak at the CBI Forecasting & ...
(Date:2/8/2010)... , Feb. 8 /PRNewswire-Asia-FirstCall/ -- ... "the Company"), a leading China -based ... marketing,biopharmaceutical products, today announced a collaboration and ... and commercialize its,Nephoxil(R) pharmaceutical product for the ... Nephoxil (ferric citrate) ...
Breaking Biology Technology:Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 43SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 23SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 33SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 4
... Murray Grossan, MD (creator of the Hydro-Pulse sinus irrigation ... anti-fungals and anti-inflammatories directly into the sinus cavities using ... helpful for his patients who experience symptoms of sinus ... ...
... 30 Nektar,Therapeutics (Nasdaq: NKTR ) will announce ... 2008 on Wednesday, August 6, 2008, after the,close of ... will host a conference call to review the results,beginning ... (PT)., The press release and a live audio-only ...
... SAN DIEGO, July 30 Anadys Pharmaceuticals,Inc. (Nasdaq: ... care by developing novel medicines in the areas of,hepatitis ... for the second quarter ended June 30, 2008., ... productive time at,Anadys," said Steve Worland, Ph.D., President and ...
Other Biology Technology:Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation 2Nektar to Announce Financial Results for the Second Quarter of 2008 on Wednesday, August 6, 2008, After Close of U.S.-Based Financial Markets 2Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 2Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 3Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 4Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 5Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 6Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights 7
(Date:2/9/2010)... the Hood Center for Children and Families at Dartmouth ... on the significant potential negative impact that food product ... , The study, which appears in the current edition ... of the "brand placements" for food, beverage, and food ... for energy-dense, nutrient-poor foods or product lines. In addition, ...
(Date:2/9/2010)... The Scripps Research Institute have discovered a potential new ... for sheep and cattle infected with liver fluke. The ... in combating river blindness, a tropical disease that is ... humans. , The study is scheduled for publication ... Proceedings of the National Academy of Sciences ...
(Date:2/9/2010)... they say is a strong candidate for involvement in ... the natural flux in hormones during the menstrual cycle. ... of the National Academy of Sciences , Rockefeller University ... human variant of the gene increases anxiety, dampens curiosity ... impairing memory. If applied in the clinic, the work ...
Breaking Biology News(10 mins):New study examines the impact on children of food product placements in the movies 2New study examines the impact on children of food product placements in the movies 3Scripps research team reveals how an old drug could have a new use for treating river blindness 2Scripps research team reveals how an old drug could have a new use for treating river blindness 3Scripps research team reveals how an old drug could have a new use for treating river blindness 4Research identifies gene with likely role in premenstrual disorder 2Research identifies gene with likely role in premenstrual disorder 3GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech 63059 1GAA Calls on President Obama to Make Good on His Nobel Peace Prize Speech 63059 2West Coast Banks Salem Battle Creek Branch is Collecting Teddy Bears for Sick Children at the Salem Hospital 63054 1Successful Stem Cell Therapy for Treatment of Eye Disease 15140 1Successful Stem Cell Therapy for Treatment of Eye Disease 15140 2Successful Stem Cell Therapy for Treatment of Eye Disease 15140 3Successful Stem Cell Therapy for Treatment of Eye Disease 15140 4
... process of how the body's nervous system relays information may ... fires a packet of neurotransmitter across a synapse to a ... University of Illinois at Chicago biology professor Simon Alford report ... of the National Academy of Sciences. , "Until recently, the ...
... cured the metabolic symptoms of 11 patients with a ... Urine Disease (MSUD), according to a study by researchers ... Special Children. , All patients from the study (ranging ... normal liver function, according to the researchers. Amino acid ...
... percent of deaths from SIDS (sudden infant death syndrome) in ... and half of those deaths result from a common genetic ... heart rhythm during times of environmental stress, a research team ... 2006 issue of the Journal of Clinical Investigation. , ...
Other Biology News:Protein receptor cools passion of 'kiss and run' nerve cells 2Pennsylvania researchers find liver transplants provide metabolic cure for rare genetic disease 2Gene variation increases SIDS risk in African Americans 2Gene variation increases SIDS risk in African Americans 3
... LC Sciences provides a genome-wide microRNA (miRNA) ... proprietary probe design, which enable highly sensitive ... We have standard arrays for mature miRNA ... version of the Sanger miRBase database (Release ...
... studies, vaccine development, and biosensor development ... Paraflo microfluidic on-chip synthesis platform. These ... our comprehensive Epitope Peptide Microarray Service. ... Probe content is completely customer specified. ...
... peptide microarrays designed for quantitative assays ... and built on the flexible and ... of customer specified sequences can be ... provide assistance with custom sequence design. ...
... first time, you can identify and characterize ... without interferences. The Agilent Multiple Affinity Removal ... high-abundant proteins from human serum, plasma, CSF ... device. With this revolutionary system, you can: ...
Biology Products: